206 related articles for article (PubMed ID: 12097420)
1. TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.
Chames P; Willemsen RA; Rojas G; Dieckmann D; Rem L; Schuler G; Bolhuis RL; Hoogenboom HR
J Immunol; 2002 Jul; 169(2):1110-8. PubMed ID: 12097420
[TBL] [Abstract][Full Text] [Related]
2. T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.
Willemsen RA; Ronteltap C; Chames P; Debets R; Bolhuis RL
J Immunol; 2005 Jun; 174(12):7853-8. PubMed ID: 15944290
[TBL] [Abstract][Full Text] [Related]
3. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
[TBL] [Abstract][Full Text] [Related]
4. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
[TBL] [Abstract][Full Text] [Related]
5. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
6. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
[TBL] [Abstract][Full Text] [Related]
8. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
[TBL] [Abstract][Full Text] [Related]
9. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
[TBL] [Abstract][Full Text] [Related]
10. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.
Denkberg G; Klechevsky E; Reiter Y
J Immunol; 2002 Oct; 169(8):4399-407. PubMed ID: 12370373
[TBL] [Abstract][Full Text] [Related]
11. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.
Kumar P; Vahedi-Faridi A; Saenger W; Ziegler A; Uchanska-Ziegler B
Protein Sci; 2009 Jan; 18(1):37-49. PubMed ID: 19177349
[TBL] [Abstract][Full Text] [Related]
13. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
[TBL] [Abstract][Full Text] [Related]
14. Rational development of high-affinity T-cell receptor-like antibodies.
Stewart-Jones G; Wadle A; Hombach A; Shenderov E; Held G; Fischer E; Kleber S; Nuber N; Stenner-Liewen F; Bauer S; McMichael A; Knuth A; Abken H; Hombach AA; Cerundolo V; Jones EY; Renner C
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5784-8. PubMed ID: 19307587
[TBL] [Abstract][Full Text] [Related]
15. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
[TBL] [Abstract][Full Text] [Related]
16. Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
Yun CO; Nolan KF; Beecham EJ; Reisfeld RA; Junghans RP
Neoplasia; 2000; 2(5):449-59. PubMed ID: 11191112
[TBL] [Abstract][Full Text] [Related]
17. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
18. Genetic engineering of T cell specificity for immunotherapy of cancer.
Willemsen RA; Debets R; Chames P; Bolhuis RL
Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
20. Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.
Purbhoo MA; Sutton DH; Brewer JE; Mullings RE; Hill ME; Mahon TM; Karbach J; Jäger E; Cameron BJ; Lissin N; Vyas P; Chen JL; Cerundolo V; Jakobsen BK
J Immunol; 2006 Jun; 176(12):7308-16. PubMed ID: 16751374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
